A Smartphone App on Medication Adherence
NCT05892120 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-06-07
Summary
This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.
Conditions
- Medication Adherence
Interventions
- BEHAVIORAL
-
the MedAdhere app
The experimental group downloaded and used the MedAdhere app on their personal smartphones during this 8-week study
Sponsors & Collaborators
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2023-07-25
- Completion
- 2023-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718 ·Status: COMPLETED ·Phase: NA
-
Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia
NCT00455663 ·Status: COMPLETED ·Phase: NA
-
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
NCT01953237 ·Status: COMPLETED ·Phase: NA
-
Patient-Centered Medication Adherence Intervention for Schizophrenia
NCT00144027 ·Status: COMPLETED ·Phase: NA
-
The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia
NCT04143308 ·Status: COMPLETED ·Phase: NA
-
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
NCT00861003 ·Status: UNKNOWN
-
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
NCT04503954 ·Status: COMPLETED ·Phase: NA
-
Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia
NCT00873249 ·Status: COMPLETED
-
Effectiveness of Adherence Therapy for Schizophrenia
NCT01780116 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
NCT04959201 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients
NCT07165821 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA
NCT06474325 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Aggressive Acts Among Patients With Schizophrenia
NCT00172497 ·Status: SUSPENDED
-
Medication Adherence in Older People With Psychosis
NCT00071604 ·Status: UNKNOWN ·Phase: NA
-
Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia
NCT00148590 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects
NCT02233556 ·Status: UNKNOWN ·Phase: NA
-
RCT of Methotrexate Added to Treatment As Usual in Schizophrenia
NCT02074319 ·Status: COMPLETED ·Phase: PHASE1
-
Artificial Intelligence to Measure Adherence to Oral Medication
NCT04046497 ·Status: RECRUITING ·Phase: PHASE4
-
Mobile Enhancement of Motivation in Schizophrenia
NCT03059771 ·Status: COMPLETED ·Phase: NA
-
Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients
NCT02850445 ·Status: UNKNOWN ·Phase: NA
-
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731 ·Status: COMPLETED
-
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
NCT04411979 ·Status: COMPLETED ·Phase: NA
-
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Financial Incentives to Improve Acceptance of Antipsychotic Injections
NCT03192631 ·Status: UNKNOWN ·Phase: NA
-
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
NCT03451734 ·Status: COMPLETED